US Patent Issued to Momenta Pharmaceuticals on Nov. 4 for "Antibodies against integrin alpha 11 beta 1" (Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,006, issued on Nov. 4, was assigned to Momenta Pharmaceuticals Inc. (Titusville, N.J.).

"Antibodies against integrin alpha 11 beta 1" was invented by Elma Kurtagic (Milton, Mass.), James W. Meador III (Needham, Mass.) and Christopher Beneduce Jr. (Medford, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure includes antibodies that specifically bind integrin alpha 11 beta 1 (Alpha11Beta1), as well as methods of making and using such antibodies."

The patent was filed on Dec. 18, 2020, under Application No. 17/757,607.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/n...